ArticlePharmaceutics2025

Preclinical Long-Term Stability and Forced Degradation Assessment of EPICERTIN, a Mucosal Healing Biotherapeutic for Inflammatory Bowel Disease.

Wendy M Kittle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.